The clinical course of renal function in NIDDM patients with normo- and microalbuminuria

Journal of Internal Medicine

Volumn 241, Issue 2, 1997, Pages 133-141

  Nielsen, S ^a,b   Schmitz, A ^a   Rehling, M ^a   Mogensen, C E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b MAYO CLINIC   (United States)

Author keywords

Blood pressure; Cardiovascular risk factors; Glomerular filtration rate; Microalbuminuria; Non insulin dependent diabetes mellitus; Urinary albumin excretion rate

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA;

EID: 0031055977     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.93107000.x     Document Type: Article

References (43)

1. FitzSimmons SC, Agodoa L, Striker L, Conti F, Striker G. Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis, and prevention. Am J Kid Dis 1989; 8: 7-10.
2. Eggers PW. Effect of transplantation on the medicare end-stage renal disease program. N Engl J Med 1993; 381: 223-9.
3. Rettig B, Teutsch SM. The incidence of end-stage renal disease in type II and type II diabetes mellitus. Diabet Nephrop 1984; 3: 26-7.
4. Grenfell A, Bewick M, Parsons V, Snowden S, Taube D, Watkins PJ. Non-insulin-dependent diabetes and renal replacement therapy. Diabet Med 1988; 5: 172-6.
5. Gall M-A, Nielsen FS, Smidt UM, Parving H-H. The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabelologia 1993; 36: 1071-8.
6. Gall M-A, Nielsen FS, Smidt UM, Parving H-H. The course of kidney function in non-insulin-dependent diabetic patients with diabetic or non-diabetic glomerulopathy (Abstract). Diabetologia 1994; 37 (Suppl. 1): A15.
7. Ravid M, Savin H, Lang R, Jutrin I, Shoshana L, Lishner M. Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. Arch Intern Med 1992; 152: 1225-9.
8. Biesenbach G, Janko O, Zazgornik J. Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant 1994; 9: 1097-102.
9. Hasslacher C, Bostedt Kiesel A, Kempe HP, Wahl P. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993; 36: 1051-6.
10. Pugh JA, Medina R, Ramirez M. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 1993; 36: 1094-8.
11. Schmitz A, Christensen T, Jensen FT. Glomerular filtration rate and kidney volume in normoalbuminuric non-insulin-dependent diabetics - lack of glomerular hyperfiltration and renal hypertrophy in uncomplicated NIDDM. Scand J Clin Lab Invest 1989; 48: 103-8.
12. Schmitz A, Christensen T, Moller A, Mogensen CE. Kidney function and cardiovascular risk factors in non-insulin-dependent diabetics (NIDDM) with microalbuminuria. J Intern Med 1990; 228: 347-52.
13. Nielsen S, Schmitz A, Rehling M, Mogensen CE. Systolic blood pressure relates to the rate of decline of glomerular filtration rate in Type 2 diabetes mellitus. Diabetes Care 1993; 16: 1427-32.
14. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-60.
15. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Risk factors for development of micro- and macroalbuminuria in non-insulin-dependent diabetes mellitus (Abstract). Diabetologia 1995; 38 (Suppl. 1): A215.
16. 1989 Guidelines for the Management of Mild Hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1989; 7: 689-93.
17. Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-74.
18. Christensen CK, Ørskov C. Rapid screening PEG immunoassay for quantification of pathological microalbuminuria. Diabet Nephrol 1984; 3: 92-94.
19. Ellis G, Diamandis EP, Giesbrecht EE, Daneman D, Allen LC. An automated 'high-pressure' liquid-chromatographic assay for hemoglobin A1c. Clin Chem 1984; 30: 1746-52.
20. Jeppsson JO, Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 1986; 32: 1867-72.
21. Lie RF, Schmitz JM, Pierre KJ, Gochman N. Cholesterol oxidase-based determination, by continuous-flow analysis, of total and free cholesterol in serum. Clin Chem 1976; 22: 1627-30.
22. Bucolo H, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-82.
23. 2+ precipitation procedure for quantification of high-density-lipoprotein cholesterol. Clin Chem 1982; 28: 1379-88.
24. Fabiny DL, Ertinghausen G. Automated reaction-rate method for determination of serum creatinine with the Centrifichem. Clin Chem 1971; 17: 696-700.
25. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol 1976; 31: 155-65.
26. Bröchner-Mortensen J, Rødbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1976; 36: 35-43.
27. Mogensen CE, Hansen KW, Nielsen S, Mau Pedersen M, Rehling M, Schmitz A. Monitoring diabetic nephropathy: Glomerular filtration rate and abnormal albuminuria in diabetic renal disease - reproducibility, progression, and efficacy of antihypertensive intervention. Am J Kid Dis 1993; 22: 174-87.
28. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med 1984; 1: 17-9.
29. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-4-1.
30. Mattock MB, Keen H, Viberti GC, el Gohari MR, Murrells TJ, Scott CS, et al. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988; 31: 82-7.
31. Schmitz A, Vaeth M. Microalbuminuria : a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 1988; 5: 126-34.
32. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993; 16: 996-1003.
33. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577-81.
34. Berrut G, Bouhanick B, Fabbri P, Guilloteau G, Lejeune JJ, Fressinaud Ph, et al. Microalbuminuria predicts glomerular filtration rate (GFR) reduction in type 2 (non insulin-dependent) diabetic subjects with hypertension (Abstract). Diabetologia 1994; 37: A45.
35. Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 1991; 302: 210-16.
36. Lacourciere V, Nadeau A, Poirier L, Tancrède G. Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis. Hypertension 1993; 21: 786-944.
37. Gambardella S, Frontoni S, Lala A, Felici MG, Spallone V, Scoppola A, et al. Regression of microalbuminuria in type II diabetic hypertensive patients after long-term indapamide treatment. Am Heart J 1991; 122: 1232-8.
38. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129-38.
39. Ruggenenti P, Mosconi L, Bianchi L, Cortesi L, Campana M, Pagani G, et al. Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. Am J Kid Dis 1994; 24: 753-61.
40. Chan JCN, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R. Comparison of enalapril and nifedipin in treating non-insulin dependent diabetes associated with hypertension: one year analysis. Br Med J 1992; 305: 981-5.
41. Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; ii: 1309-11.
42. Kasiske BL, O'Donnell MP, Cowardin W, Keane WF. Lipids and the kidney. Hypertension 1990: 15(5): 443-50.
43. Nielsen S, Schmitz O, Møller N, Pørksen N, Klausen IC, Alberti KGMM, et al. Renal function and insulin sensitivity during simvastatin treatment in Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1993; 36: 1079-86.